Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05485376 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pulmonary Artery Catheter in Cardiogenic Shock Trial

Study acronym: PACCS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 29, 2025 (before its estimated September 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Sep 1, 2025 to Sep 1, 2026v6
  2. Site contact updatedv5
  3. Trial status: Enrolling by Invitation to Recruiting Site details revisedv4 Show 1 more changeShow less
    • Site details revised
  4. Start date changed from estimate of Sep 1, 2022 to Aug 23, 2022v3
  5. Trial status: Not Yet Recruiting to Enrolling by Invitation Start date: Aug 1, 2022 to Sep 1, 2022 · Primary completion date: Aug 1, 2025 to Sep 1, 2025 · Completion date: Aug 1, 2026 to Sep 1, 2026 · 1 morev2 Show 4 more changesShow less
    • Start date: Aug 1, 2022 to Sep 1, 2022
    • Primary completion date: Aug 1, 2025 to Sep 1, 2025
    • Completion date: Aug 1, 2026 to Sep 1, 2026
    • Site contact updated
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objective of the PACCS trial is to assess if early invasive hemodynamic assessment and ongoing management with a PAC in patients with cardiogenic shock due to acutely decompensated heart failure (AHDF-CS) is associated with lower in-hospital mortality risk compared to the current standard of care with no or delayed PAC assessment.
Trial Details
NCT Number NCT05485376
Lead Sponsor Tufts Medical Center
Conditions Cardiogenic Shock, Heart Failure
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov